CHPA leadership
This article was originally published in The Tan Sheet
Executive Summary
Perrigo Consumer Healthcare Executive VP & General Manager John Hendrickson has been named chair-elect of the Consumer Healthcare Products Association's Board of Directors, according to a Nov. 22 announcement. The CHPA board chose Hendrickson for the two-year position during a recent meeting; he will assume his role following a vote by members during the group's annual meeting in March. Hendrickson, who will replace current chair Timothy Hayes of Bayer Healthcare, was elected to CHPA's Board of Directors and the Executive Committee in 2004. In 2005 he was elected chair of the Finance Committee. Hendrickson worked for Procter & Gamble in product and consumer research before joining Perrigo in 1989. He also serves on the National Association of Chain Drug Stores' Advisory Board and the Michigan Chamber of Commerce Board of Directors...
You may also be interested in...
CHPA board
Perrigo Consumer Healthcare Executive VP & General Manager John Hendrickson has been elected chair of the Consumer Healthcare Products Association by the group's Board of Directors, CHPA announces March 17 during its annual meeting in Aventura, Fla. The group announced Hendrickson as chair-elect in November (1"The Tan Sheet" Nov. 28, 2005, In Brief). Hendrickson succeeds Timothy Hayes of Bayer Healthcare, who will now serve as immediate past chair. In addition, the association, which was founded in 1881, is celebrating its 125th anniversary by unveiling a new, more "modern" logo, President Linda Suydam said...
TheOTCLab Scores Dutch Distribution Rights To Just For Men, Vagisil and Breathe Right
Dutch firm TheOTCLab expands its home market presence with distribution rights to three international consumer health brands: Combe's feminine health brand Vagisil and male hair care range Just For Men and Foundation Consumer Brands’ Breathe Right Nasal Strips.
Alvotech And Cipla Expand Biosimilars Deal For Australia And New Zealand
Cipla has expanded its partnership with Alvotech to cover the commercialization of five biosimilars in Australia and New Zealand, building on an existing alliance covering South Africa and emerging markets.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: